Evidence map›Paper›PMID 30702751›Full record

ReviewJournal of neurochemistry2019

Inflammatory mechanisms in neurodegeneration.

Michael R Nichols, Marie-Kim St-Pierre, Ann-Christin Wendeln, Nyasha J Makoni, Lisa K Gouwens, Evan C Garrad, Mona Sohrabi, Jonas J Neher, Marie-Eve Tremblay, Colin K Combs

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of neurochemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 1 synthesis or guideline pooled it, 122 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Evaluation of [AJNR. American journal of neuroradiology · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Inflammaging and Brain Aging.International journal of molecular sciences · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Michael R NicholsDepartment of Chemistry & Biochemistry, University of Missouri-St. Louis, St. Louis, Missouri, USA.ORCID 0000-0001-5458-218X
Marie-Kim St-PierreAxe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval, Québec, Quebec, Canada.
Ann-Christin WendelnGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.ORCID 0000-0003-4586-6281
Nyasha J MakoniDepartment of Chemistry & Biochemistry, University of Missouri-St. Louis, St. Louis, Missouri, USA.
Lisa K GouwensDepartment of Chemistry & Biochemistry, University of Missouri-St. Louis, St. Louis, Missouri, USA.
Evan C GarradDepartment of Chemistry & Biochemistry, University of Missouri-St. Louis, St. Louis, Missouri, USA.
Mona SohrabiDepartment of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, USA.
Jonas J NeherGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Marie-Eve TremblayAxe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval, Québec, Quebec, Canada.ORCID 0000-0003-2863-9626
Colin K CombsDepartment of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, USA.
University of Missouri–St. Louis · USGerman Center for Neurodegenerative Diseases · DEUniversité Laval · CAUniversity of North Dakota · US

Funding

Structural and Cellular Features Linking Amyloid-Beta with Immune ActivityR15AG033913 · NIA · UNIVERSITY OF MISSOURI-ST. LOUIS · PI NICHOLS, MICHAEL R. · 2009 to 2011
$550k
Oligomerization State and Function of the NLRP3 InflammasomeR15GM119070 · NIGMS · UNIVERSITY OF MISSOURI-ST. LOUIS · PI NICHOLS, MICHAEL R. · 2016 to 2016
$439k
CIHRNIA NIH HHS R15 AG033913NIGMS NIH HHS R15 GM119070
6 · The paper itself

Abstract

This review discusses the profound connection between microglia, neuroinflammation, and Alzheimer's disease (AD). Theories have been postulated, tested, and modified over several decades. The findings have further bolstered the belief that microglia-mediated inflammation is both a product and contributor to AD pathology and progression. Distinct microglia phenotypes and their function, microglial recognition and response to protein aggregates in AD, and the overall role of microglia in AD are areas that have received considerable research attention and yielded significant results. The following article provides a historical perspective of microglia, a detailed discussion of multiple microglia phenotypes including dark microglia, and a review of a number of areas where microglia intersect with AD and other pathological neurological processes. The overall breadth of important discoveries achieved in these areas significantly strengthens the hypothesis that neuroinflammation plays a key role in AD. Future determination of the exact mechanisms by which microglia respond to, and attempt to mitigate, protein aggregation in AD may lead to new therapeutic strategies.

Indexed as

Alzheimer DiseaseAnimalsHumansInflammationMicrogliaNerve DegenerationAlzheimer's diseaseamyloid-betamicroglianeuroinflammation

Identifiers

PMID30702751
PMCPMC6541515
OpenAlexW2914406467

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.